CAIX-specific CAR-T Cells and Sunitinib Show Synergistic Effects Against Metastatic Renal Cancer ModelsHuizhong Li, Qing Zhang, Jiage Ding et al.|Journal of Immunotherapy|2019Cited by 97
Lenvatinib enhances T cell immunity and the efficacy of adoptive chimeric antigen receptor-modified T cells by decreasing myeloid-derived suppressor cells in cancerMengmeng Lü, Qing Zhang, Chao Huang et al.|Pharmacological Research|2021Cited by 50
Lenvatinib promotes antitumor immunity by enhancing the tumor infiltration and activation of NK cells.Qing Zhang, Junnian Zheng, Hongyan Liu et al.|PubMed|2019Cited by 44
Akt inhibition at the initial stage of CAR-T preparation enhances the CAR-positive expression rate, memory phenotype and in vivo efficacy.Qing Zhang, Junnian Zheng, Jiage Ding et al.|PubMed|2019Cited by 44
Bortezomib improves adoptive carbonic anhydrase�IX‑specific chimeric antigen receptor‑modified NK92 cell therapy in mouse models of human renal cell carcinomaQing Zhang, Junnian Zheng, Jǐnjīng Xǔ et al.|Oncology Reports|2018Cited by 29